PlainRecalls
FDA Drug Low Class III Terminated

Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

Reported: September 28, 2016 Initiated: March 24, 2016 #D-1516-201

Product Description

Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Expiration Date

Details

Recalling Firm
Lupin Limited
Units Affected
3,192 bottles (319,200 tablets)
Distribution
Nationwide
Location
Verna, Salcette, Goa

Frequently Asked Questions

What product was recalled?
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01. Recalled by Lupin Limited. Units affected: 3,192 bottles (319,200 tablets).
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Expiration Date
Which agency issued this recall?
This recall was issued by the FDA Drug on September 28, 2016. Severity: Low. Recall number: D-1516-201.